KI2011 is a novel potent FLT3 tyrosine kinase inhibitor in acute myeloid leukemia cells with FLT3-mutation

被引：0
|
作者：
Ryu, Hwani [1 ]
Song, Jie-Young [1 ]
Ahn, Jiyeon [1 ]
机构：
[1] Korea Inst Radiol & Med Sci, Seoul, South Korea
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-806
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
806
引用
收藏
页数：2
相关论文
共 50 条
  • [31] FLT3 inhibitors in acute myeloid leukemia
    不详
    ANNALS OF HEMATOLOGY, 2008, 87 : S87 - S89
  • [32] FLT3 Inhibitors for Acute Myeloid Leukemia
    Lancet, Jeffrey E.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 573 - 575
  • [33] FLT3 inhibitors in acute myeloid leukemia
    el-Shami, Khaled
    Stone, Richard M.
    Smith, B. Douglas
    EXPERT REVIEW OF HEMATOLOGY, 2008, 1 (02) : 153 - 160
  • [34] FLT3 inhibitors in acute myeloid leukemia
    Pastore, Domenico
    DRUGS AND CELL THERAPIES IN HEMATOLOGY, 2016, 4 (01): : 14 - 21
  • [35] Novel FLT3 tyrosine kinase inhibitors
    Levis, M
    Small, D
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (12) : 1951 - 1962
  • [36] GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia
    Xinhua Xiao
    Peihong Wang
    Weina Zhang
    Jiayi Wang
    Mansi Cai
    Hua Jiang
    Yingli Wu
    Huizhuang Shan
    Cancer Cell International, 23
  • [37] Activation of protein phosphatase 2A in FLT3+acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors
    Smith, Amanda M.
    Dun, Matthew D.
    Lee, Erwin M.
    Harrison, Celeste
    Kahl, Richard
    Flanagan, Hayley
    Panicker, Nikita
    Mashkani, Baratali
    Don, Anthony S.
    Morris, Jonathan
    Toop, Hamish
    Lock, Richard B.
    Powell, Jason A.
    Thomas, Daniel
    Guthridge, Mark A.
    Moore, Andrew
    Ashman, Leonie K.
    Skelding, Kathryn A.
    Enjeti, Anoop
    Verrills, Nicole M.
    ONCOTARGET, 2016, 7 (30) : 47465 - 47478
  • [38] Metabolic alterations and drug sensitivity of tyrosine kinase inhibitor resistant leukemia cells with a FLT3/ITD mutation
    Huang, Amin
    Ju, Huai-Qiang
    Liu, Kaiyan
    Zhan, Guilian
    Liu, Daolu
    Wen, Shijun
    Garcia-Manero, Guillermo
    Huang, Peng
    Hu, Yumin
    CANCER LETTERS, 2016, 377 (02) : 149 - 157
  • [39] FLT3 Kinase Inhibitor TTT-3002 Overcomes Both Activating and Drug Resistance Mutations in FLT3 in Acute Myeloid Leukemia
    Ma, Hayley S.
    Bao Nguyen
    Duffield, Amy S.
    Li, Li
    Galanis, Allison
    Williams, Allen B.
    Brown, Patrick A.
    Levis, Mark J.
    Leahy, Daniel J.
    Small, Donald
    CANCER RESEARCH, 2014, 74 (18) : 5206 - 5217
  • [40] Novel AXL-targeted agents overcome FLT3 inhibitor resistance in FLT3-ITD+ acute myeloid leukemia cells
    Liu, Yi
    Wei, Jing
    Liu, Jiaxin
    Ma, Weina
    Duan, Yanting
    Liu, Daihong
    ONCOLOGY LETTERS, 2021, 21 (05)
12345